🌍·14h agoResearch
Asciminib monotherapy in patients with BCR::ABL1 T315I-mutated chronic-phase chronic myeloid leukemia: phase 1 trial final results
Publisher
C
Crossref
Global
This page provides a limited summary and publisher metadata to support discovery before sending readers to the original article.
Read originalAt a glance
- Publisher
- Crossref
- Region
- Global
- Scope
- Research
- Published
- July 16, 2026
- Language
- EN
In-platform summary, original article off-platform
This page presents the title, publisher metadata, and a limited summary excerpt to help users judge relevance first. Full-text reading stays on the publisher's original site.
Source route
Continue on doi.org
Leave the platform to read the original full article on the publisher site.
Source: Crossref
Scope: Research
Related coverage
More related coverage
Manchester University NHS Foundation Trust/5h ago
Antimicrobial Resistance lab gets Gold Award for sustainability
Universitätsklinikum Heidelberg/6h ago
Von „Rain Man“ bis „Love on the Spectrum“ – Was Sie schon immer über Autismus wissen wollten!
UNMC/7h ago
Ribbon cutting is Friday for UNMC Residences
Hospital Clínic de Barcelona/7h ago